Trial · NCT03375489
Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer
NCT03375489, Not applicable, Completed, Massachusetts General Hospital; results first posted 2025-05-16
3 sourcestrials-2026-11-12-0.5.0
Download JSON
Cite this record
ConductScience Library. Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer. Trials, record NCT03375489. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03375489
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer
- NCT number
- NCT03375489
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 1,798 participants, actual
- Lead sponsor
- Massachusetts General Hospital
- Conditions
- Lung Cancer
- Interventions
- Telehealth Palliative Care, In-person Palliative Care
- First posted
- 2017-12-18
- Last updated
- 2025-05-16
- Results first posted
- 2025-05-16
Source ClinicalTrials.gov
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Patient-reported Quality of Life | 24 Weeks | Compare the difference between study groups in patient-reported quality of life as measured by the Functional Assessment of Cancer Therapy - Lung Questionnaire, which has a total scale score range from 0-136 with higher scores indicating better overall quality of life. |
| Secondary | Patient-reported Communication About Their End-of-Life Care Preferences With Their Clinicians | 48 weeks (or last assessment prior to death if before 48 weeks) | Compare the difference between study groups in the proportion of patients who reported that they discussed their end-of-life care preferences with their clinicians based on a single item from the Prognosis and Treatment Perceptions Questionnaire (PTPQ). The PTPQ includes a self-report item that assesses whether the patient communicated with their clinicians about their wishes for care if they were dying (i.e., scored dichotomously as "yes vs. no"). |
| Secondary | Length of Stay in Hospice | From hospice enrollment until patient death during study period | Compare the difference between study groups in the length of stay in hospice (as measured in days) among patients who died during study period per medical record review. |
| Secondary | Proportion of Patient's Palliative Care Visits With a Caregiver Present | 24 weeks | Compare the difference between study groups in the proportion of palliative care visits that had a caregiver present as documented by the palliative care clinician using a study visit summary form. |
| Secondary | Patient-reported Satisfaction With Care | 24 weeks | Compare the difference between study groups in patient-reported satisfaction with care as measured by the Satisfaction and Care Delivery Questionnaire, which has a total scale score range from 0-52 with higher scores indicating greater satisfaction. |
| Secondary | Caregiver-reported Satisfaction With Care | 24 weeks | Compare the difference between study groups in caregiver-reported satisfaction with care as measured by the Satisfaction and Care Delivery Questionnaire (caregiver version), which has a total scale score range from 0-48 with higher scores indicating greater satisfaction. |
| Other | Patient-reported Coping Strategies | up to 48 weeks | Compare the difference between study groups in patient-reported coping strategies as measured by the Brief Cope (approach-oriented coping score range: 6-24, with higher scores indicating greater use of approach-oriented coping strategies; avoidant coping score range: 4-16, with higher scores indicating greater use of avoidant coping strategies). |
| Other | Patient-reported Prognostic Understanding | up to 48 weeks | Compare the difference between study groups in patient-reported prognostic understanding as measured by the Prognosis and Treatment Perceptions Questionnaire, in which patients rate two items about the goal of their cancer care (i.e., scored dichotomously as either "to cure my cancer" vs any other option) and whether their cancer is curable (i.e., scored dichotomously as "yes or no"). |
| Other | Caregiver-reported Prognostic Understanding | up to 48 weeks | Compare the difference between study groups in caregiver-reported prognostic understanding as measured by the Prognosis and Treatment Perceptions Questionnaire, in which caregivers rate two items about the goal of their loved one's cancer care (i.e., scored dichotomously as either "to cure his/her cancer" vs any other option) and whether their loved one's cancer is curable (i.e., scored dichotomously as "yes or no"). |
| Other | Caregiver-reported Quality of Life | up to 48 weeks | Compare the difference between study groups in caregiver-reported quality of life as measured by the Caregiver Oncology Quality of Life Questionnaire, which has a total scale score range of 0-100 with higher scores indicating better quality of life. |
1 to 10 of 16Source ClinicalTrials.gov
See all 16 registered outcomesOutcomes16
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Patient-reported Quality of Life | 24 Weeks | The analysis population represents the numbers of patients in each study group who completed the baseline and 24-week Functional Assessment of Cancer Therapy - Lung Questionnaire. | units on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Patient-reported Communication About Their End-of-Life Care Preferences With Their Clinicians | 48 weeks (or last assessment prior to death if before 48 weeks) | The analysis population represents the numbers of patients in each study group who completed the Prognosis and Treatment Perceptions Questionnaire at least once post baseline up to 48 weeks. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Length of Stay in Hospice | From hospice enrollment until patient death during study period | The analysis population represents the numbers of patients in each study group who who died during the study period. | days | LEAST_SQUARES_MEAN |
| SECONDARY | Proportion of Patient's Palliative Care Visits With a Caregiver Present | 24 weeks | The analysis population represents the numbers of patients in each study group who had any palliative care visits, and the overall number of units analyzed represents the numbers of palliative care visits in each study group through week 24. | proportion of visits with a caregiver | NUMBER |
| SECONDARY | Patient-reported Satisfaction With Care | 24 weeks | The analysis population represents the numbers of patients in each study group who completed the 24-week Satisfaction and Care Delivery Questionnaire. | units on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Caregiver-reported Satisfaction With Care | 24 weeks | The analysis population represents the numbers of caregivers in each study group who completed the 24-week Satisfaction and Care Delivery Questionnaire. | units on a scale | LEAST_SQUARES_MEAN |
| OTHER_PRE_SPECIFIED | Patient-reported Coping Strategies | up to 48 weeks | |||
| OTHER_PRE_SPECIFIED | Patient-reported Prognostic Understanding | up to 48 weeks | |||
| OTHER_PRE_SPECIFIED | Caregiver-reported Prognostic Understanding | up to 48 weeks | |||
| OTHER_PRE_SPECIFIED | Caregiver-reported Quality of Life | up to 48 weeks |
1 to 10 of 16Source ClinicalTrials.gov
See all 16 outcomesResults by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Patient-reported Quality of Life | Telehealth Palliative Care: Patients | 99.7 | 95% Confidence Interval 98.0 to 101.3 | units on a scale | |
| Patient-reported Quality of Life | In-person Palliative Care: Patients | 97.7 | 95% Confidence Interval 96.1 to 99.3 | units on a scale | |
| Patient-reported Communication About Their End-of-Life Care Preferences With Their Clinicians | Telehealth Palliative Care: Patients | 130 | Participants | ||
| Patient-reported Communication About Their End-of-Life Care Preferences With Their Clinicians | In-person Palliative Care: Patients | 115 | Participants | ||
| Length of Stay in Hospice | Telehealth Palliative Care: Patients | 25.3 | 95% Confidence Interval 19.2 to 31.3 | days | |
| Length of Stay in Hospice | In-person Palliative Care: Patients | 25.1 | 95% Confidence Interval 19.0 to 31.1 | days | |
| Proportion of Patient's Palliative Care Visits With a Caregiver Present | Telehealth Palliative Care: Patient | 36.6 | 95% Confidence Interval 33.6 to 39.7 | proportion of visits with a caregiver | |
| Proportion of Patient's Palliative Care Visits With a Caregiver Present | In-person Palliative Care: Patient | 49.7 | 95% Confidence Interval 46.4 to 53.1 | proportion of visits with a caregiver | |
| Patient-reported Satisfaction With Care | Telehealth Palliative Care: Patient | 41.3 | 95% Confidence Interval 40.4 to 42.3 | units on a scale | |
| Patient-reported Satisfaction With Care | In-person Palliative Care: Patient | 41.0 | 95% Confidence Interval 40.1 to 41.9 | units on a scale |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 results by groupParticipant flow12
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Telehealth Palliative Care: Patient | 633 | |
| Overall Study | STARTED | In-person Palliative Care: Patient | 617 | |
| Overall Study | STARTED | Telehealth Palliative Care: Caregiver | 272 | |
| Overall Study | STARTED | In-person Palliative Care: Caregiver | 276 | |
| Overall Study | COMPLETED | Telehealth Palliative Care: Patient | 633 | |
| Overall Study | COMPLETED | In-person Palliative Care: Patient | 617 | |
| Overall Study | COMPLETED | Telehealth Palliative Care: Caregiver | 272 | |
| Overall Study | COMPLETED | In-person Palliative Care: Caregiver | 276 | |
| Overall Study | NOT COMPLETED | Telehealth Palliative Care: Patient | 0 | |
| Overall Study | NOT COMPLETED | In-person Palliative Care: Patient | 0 |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 participant flowAdverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Telehealth Palliative Care: Patients | 365 | 633 |
| Total, all-cause mortality | In-person Palliative Care: Patients | 368 | 617 |
| Total, other adverse events | Telehealth Palliative Care: Patients | 0 | 0 |
| Total, other adverse events | In-person Palliative Care: Patients | 0 | 0 |
| Total, serious adverse events | Telehealth Palliative Care: Patients | 0 | 0 |
| Total, serious adverse events | In-person Palliative Care: Patients | 0 | 0 |
Source ClinicalTrials.gov
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Telehealth Palliative Care: Patients vs In-person Palliative Care: Patients: Patient-reported Communication About Their End-of-Life Care Preferences With Their Clinicians | Trial comparisons |
| Telehealth Palliative Care: Patients vs In-person Palliative Care: Patients: deaths from any cause | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03375489
GET https://conductscience.org/api/trials/v1/NCT03375489/registered